Monograph
A02BD08 - Bismuth Subcitrate, Tetracycline and Metronidazole |
Propably not porphyrinogenic |
PNP |
Rationale
Bismuth subcitrate, tetracycline and metronidazole are all classified as probably not porphyrinogenic, and therefore this combination product is also regarded probably not porphyrinogenic.
For details of the characteristics of each substance and the rationale behind the classifications, please search the individual substances bismuth subcitrate (ATC A02BX05), tetracycline (ATC J01AA07) and metronidazole (J01XD01) in this database.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Belgium
Tryplera · Tryplera 140 mg - 125 mg - 125 mg gél.United Kingdom
Pylera · Pylera 140mg/125mg/125mg capsulesPoland
Pylera
© NAPOS 2024